Xiong Y. Liu

Shenzhen, 518060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

BRCA1 deficiency promotes DNA damage in cochlear hair cells with activation of ATM-p53 pathway independent of CHK2.

BRCA1 deficiency promotes DNA damage in cochlear hair cells with activation of ATM-p53 pathway independent of CHK2.

Journal: Hearing research

Published: May 15, 2025

DDX21 Promotes Breast Cancer Growth and Metastasis via Stimulating RNAPII Elongation During Hypoxia.

DDX21 Promotes Breast Cancer Growth and Metastasis via Stimulating RNAPII Elongation During Hypoxia.

Journal: MedComm

Published: May 13, 2025

USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion.

USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion.

Journal: The Journal of biological chemistry

Published: April 17, 2024

Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer.

Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer.

Journal: Scientific reports

Published: March 14, 2024

USP11 deubiquitinates E-cadherin and maintains the luminal fate of mammary tumor cells to suppress breast cancer.

USP11 deubiquitinates E-cadherin and maintains the luminal fate of mammary tumor cells to suppress breast cancer.

Journal: The Journal of biological chemistry

Published: February 04, 2024

VHL suppresses UBE3B-mediated breast tumor growth and metastasis.

VHL suppresses UBE3B-mediated breast tumor growth and metastasis.

Journal: Cell death & disease

Published: January 07, 2024

p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.

p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.

Journal: Cell cycle (Georgetown, Tex.)

Published: June 22, 2023

SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer.

SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer.

Journal: Scientific reports

Published: June 06, 2023

UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation.

UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation.

Journal: Oncogene

Published: May 21, 2023

GATA3 functions downstream of BRCA1 to promote DNA damage repair and suppress dedifferentiation in breast cancer.

GATA3 functions downstream of BRCA1 to promote DNA damage repair and suppress dedifferentiation in breast cancer.

Journal: BMC biology

Published: March 30, 2023

Helicobacter pylori infection and risk of cardiovascular disease.

Helicobacter pylori infection and risk of cardiovascular disease.

Journal: Helicobacter

Published: January 05, 2023

Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.

Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.

Journal: Cell death & disease

Published: November 25, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026